Novartis
$84.859876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$84.85
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.77 (-0.90%) Today
$0.00 (0.00%) As of 8:00 PM EDT after-hours
Why Robinhood?
You can buy or sell Novartis and other stocks, options, ETFs, and crypto commission-free!
About NVS
Novartis AG, also called Novartis, is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. Read More The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.
Employees
103,914
Headquarters
Basel, Basel-Stadt (Basle Town)
Founded
1996
Market Cap
192.19B
Price-Earnings Ratio
27.83
Dividend Yield
2.34
Average Volume
2.16M
High Today
$85.58
Low Today
$84.52
Open Price
$84.97
Volume
2.25M
52 Week High
$99.84
52 Week Low
$69.18
Collections
Analyst Ratings
60%
of 25 ratings
Buy
60%
Hold
32%
Sell
8%
NVS Earnings
$0.00
$0.47
$0.94
$1.41
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Expected Apr 28, Pre-Market